Lisa Flaum

1.3k total citations
32 papers, 535 citations indexed

About

Lisa Flaum is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lisa Flaum has authored 32 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 22 papers in Cancer Research and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lisa Flaum's work include Cancer Genomics and Diagnostics (19 papers), Cancer Cells and Metastasis (13 papers) and Genetic factors in colorectal cancer (7 papers). Lisa Flaum is often cited by papers focused on Cancer Genomics and Diagnostics (19 papers), Cancer Cells and Metastasis (13 papers) and Genetic factors in colorectal cancer (7 papers). Lisa Flaum collaborates with scholars based in United States, Italy and China. Lisa Flaum's co-authors include William J. Gradishar, Massimo Cristofanilli, Ami N. Shah, Leonidas C. Platanias, Andrew A. Davis, Cesar A. Santa‐Maria, Francis J. Giles, Sarika Jain, Alfred Rademaker and Amir Behdad and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Lisa Flaum

31 papers receiving 534 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lisa Flaum United States	11	370	299	207	127	81	32	535
Anton Safonov United States	7	321 0.9×	135 0.5×	134 0.6×	127 1.0×	110 1.4×	36	451
Zaoke He China	7	299 0.8×	202 0.7×	199 1.0×	197 1.6×	150 1.9×	8	545
L Ryvo Israel	5	462 1.2×	140 0.5×	173 0.8×	95 0.7×	167 2.1×	8	544
Hanne Lind United States	5	336 0.9×	134 0.4×	128 0.6×	150 1.2×	152 1.9×	7	496
Marián Karaba Slovakia	13	275 0.7×	217 0.7×	62 0.3×	228 1.8×	60 0.7×	25	465
Yang Peng China	13	206 0.6×	204 0.7×	123 0.6×	228 1.8×	42 0.5×	44	485
Sara Jansson Sweden	8	374 1.0×	209 0.7×	92 0.4×	132 1.0×	123 1.5×	13	491
Miao Ruan China	5	204 0.6×	127 0.4×	115 0.6×	126 1.0×	111 1.4×	10	354
Ding Cheng Gao United States	3	216 0.6×	82 0.3×	137 0.7×	189 1.5×	61 0.8×	6	385
David Malaka United States	5	344 0.9×	228 0.8×	49 0.2×	125 1.0×	159 2.0×	6	537

Countries citing papers authored by Lisa Flaum

Since Specialization

Citations

This map shows the geographic impact of Lisa Flaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Flaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Flaum more than expected).

Fields of papers citing papers by Lisa Flaum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Flaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Flaum. The network helps show where Lisa Flaum may publish in the future.

Co-authorship network of co-authors of Lisa Flaum

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Flaum. A scholar is included among the top collaborators of Lisa Flaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Flaum. Lisa Flaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Davis, Andrew A., Ian S. Hagemann, Amir Behdad, et al.. (2025). Molecular Characterization of Patients with Metastatic Invasive Lobular Carcinoma: Using Real-World Data to Describe This Unique Clinical Entity. Clinical Cancer Research. 31(21). 4485–4494.

Gerratana, Lorenzo, Andrew A. Davis, Paolo D’Amico, et al.. (2024). Early Evaluation of Risk Stratification and Clinical Outcomes for Patients with Advanced Breast Cancer through Combined Monitoring of Baseline Circulating Tumor Cells and DNA. Clinical Cancer Research. 30(16). 3470–3480. 2 indexed citations

Vidula, Neelima, Senthil Damodaran, Manali Bhave, et al.. (2024). Abstract PO4-19-06: Phase II study of a PARP inhibitor, talazoparib, in HER2- metastatic breast cancer with a somatic BRCA1/2 mutation present in cell-free DNA or tumor tissue genotyping. Cancer Research. 84(9_Supplement). PO4–19. 1 indexed citations

Zhang, Qiang, Weijun Qin, Paolo D’Amico, et al.. (2022). ESR1 mutations in circulating tumor DNA (ctDNA) are associated with CTCs and increased hormone receptors in metastatic tumor tissues of patients with metastatic breast cancer (MBC).. Journal of Clinical Oncology. 40(16_suppl). 1057–1057. 1 indexed citations

Jacob, Saya, Andrew A. Davis, Lorenzo Gerratana, et al.. (2021). The Use of Serial Circulating Tumor DNA to Detect Resistance Alterations in Progressive Metastatic Breast Cancer. Clinical Cancer Research. 27(5). 1361–1370. 35 indexed citations

Jacob, Saya, Andrew A. Davis, Paolo D’Amico, et al.. (2021). Abstract PS2-10: Circulating tumor DNA (ctDNA) as a diagnostic tool to identify putative germline BRCA mutations. Cancer Research. 81(4_Supplement). PS2–10. 1 indexed citations

Davis, Andrew A., Saya Jacob, Lorenzo Gerratana, et al.. (2020). Landscape of circulating tumour DNA in metastatic breast cancer. EBioMedicine. 58. 102914–102914. 43 indexed citations

Davis, Andrew A., Saya Jacob, Lorenzo Gerratana, et al.. (2020). Abstract P5-01-08: Landscape of circulating tumor DNA (ctDNA) in metastatic breast cancer. Cancer Research. 80(4_Supplement). P5–1. 1 indexed citations

Davis, Andrew A., Qiang Zhang, Lorenzo Gerratana, et al.. (2019). Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer. Breast Cancer Research. 21(1). 137–137. 42 indexed citations

10.

Rademaker, Alfred, Dachao Liu, Sarika Jain, et al.. (2019). Relationship of pathological features and a 21 gene expression assay in younger versus older women with node-negative endocrine receptor-positive breast cancer. Breast Cancer Research and Treatment. 176(1). 95–100. 3 indexed citations

11.

Gerratana, Lorenzo, Qiang Zhang, Ami N. Shah, et al.. (2019). Performance of a novel Next Generation Sequencing circulating tumor DNA (ctDNA) platform for the evaluation of samples from patients with metastatic breast cancer (MBC). Critical Reviews in Oncology/Hematology. 145. 102856–102856. 15 indexed citations

12.

Gerratana, Lorenzo, Giovanna Rossi, Chenhui Wang, et al.. (2019). Abstract P3-01-19: HER2-positive circulating tumor cells (CTCs) in advanced breast cancer (BC): A feature independent of BC subtype. Cancer Research. 79(4_Supplement). P3–1. 2 indexed citations

13.

Gerratana, Lorenzo, Qiang Zhang, Ami N. Shah, et al.. (2019). Can the enumeration of circulating tumor cells (CTCs) and the characterization of circulating tumor DNA (ctDNA) provide insight into organ tropism in metastatic breast cancer (MBC)?. Journal of Clinical Oncology. 37(15_suppl). 3038–3038. 1 indexed citations

14.

Zhang, Qiang, Lorenzo Gerratana, Ami N. Shah, et al.. (2019). Abstract 429: Increased chromatin heterogeneity in circulating tumor cells (CTCs) is associated with high levels of HER2 expression in metastatic breast cancer (MBC). Cancer Research. 79(13_Supplement). 429–429. 2 indexed citations

15.

Flaum, Lisa & William J. Gradishar. (2018). Advances in Endocrine Therapy for Postmenopausal Metastatic Breast Cancer. Cancer treatment and research. 173. 141–154. 14 indexed citations

16.

Kato, Taigo, Jae‐Hyun Park, Kazuma Kiyotani, et al.. (2018). A pilot study of durvalumab and tremelimumab and immunogenomic dynamics in metastatic breast cancer. Oncotarget. 9(27). 18985–18996. 99 indexed citations

17.

Costa, Ricardo, Cesar A. Santa‐Maria, Denise Scholtens, et al.. (2017). A pilot study of cabergoline for the treatment of metastatic breast cancer. Breast Cancer Research and Treatment. 165(3). 585–592. 16 indexed citations

18.

Chae, Young Kwang, Andrew A. Davis, Sarika Jain, et al.. (2017). Concordance of Genomic Alterations by Next-Generation Sequencing in Tumor Tissue versus Circulating Tumor DNA in Breast Cancer. Molecular Cancer Therapeutics. 16(7). 1412–1420. 100 indexed citations

19.

Santa-Maria, Cesar Augusto, Priya Kumthekar, Alfred Rademaker, et al.. (2017). A pilot study of palbociclib in patients with HER2-positive breast cancer with brain metastasis.. Journal of Clinical Oncology. 35(15_suppl). TPS1110–TPS1110. 4 indexed citations

20.

Kircher, Sheetal, Sofia F. Garcia, Karen E. Kinahan, et al.. (2017). Use of a best-practice advisory to increase survivorship clinic referrals.. Journal of Clinical Oncology. 35(5_suppl). 53–53. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact